Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer
2022 · Cancer Discovery · 339 citations
https://doi.org/10.1158/2159-8290.cd-22-1066
W
William P. Vostrejs
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
550
Citations
5
h-index
4
i10-index
William P. Vostrejs is an academic researcher from UPMC Hillman Cancer Center. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Cancer Research and Treatments & Cancer Immunotherapy and Biomarkers. The author has an h-index of 5, co-authored 47 publications.
ORCID: 0000-0002-1659-0186Papers by this author
worksTumour-selective activity of RAS-GTP inhibition in pancreatic cancer
2024 · Nature · 157 citations
https://doi.org/10.1038/s41586-024-07379-z
T-cell Dependency of Tumor Regressions and Complete Responses with RAS(ON) Multi-selective Inhibition in Preclinical Models of Pancreatic Ductal Adenocarcinoma
2025 · Cancer Discovery · 26 citations
https://doi.org/10.1158/2159-8290.cd-24-1475
The YBX3 RNA-binding protein posttranscriptionally controls SLC1A5 mRNA in proliferating and differentiating skeletal muscle cells
2023 · Journal of Biological Chemistry · 10 citations
https://doi.org/10.1016/j.jbc.2023.105602
Evidence for in vitro extensive proliferation of adult hepatocytes and biliary epithelial cells
2023 · Stem Cell Reports · 5 citations
https://doi.org/10.1016/j.stemcr.2023.05.016
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat